Any feedback?
Literature summary for 3.4.21.6 extracted from
- Oral anticoagulation with factor Xa and thrombin inhibitors: on the threshold of change (2009), Curr. Opin. Hematol., 16, 347-356.
Application
| Application | Comment | Organism |
|---|---|---|
| drug development | factor Xa is a target for development of anticoagulant therapeutics, drug development and clinical trials. overview | Homo sapiens |
Inhibitors
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| apixaban | i.e. BMS-562247 | Homo sapiens |  |
| dabigatran etexilate | i.e. Rendix, Pradaxa | Homo sapiens | |
| rivaroxaban | i.e. Xarelto | Homo sapiens | |
| warfarin | - |
Homo sapiens | |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | - |
- |
- |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| factor Xa | - |
Homo sapiens |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
